Continued Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* Julius M. Gardin (Vice Chair) Hackensack University Medical Center Professor and Chairman, Department of Internal Medicine Arena Pharmaceuticals (Expired Dec. 2008) AstraZeneca (Expired Bristol-Myers Squibb (Expired Dec. 2009) CV Therapeutics (Expired Dec. 2007) Pfizer (Expired Dec. Sanofi-aventis Takeda (Expired Bristol-Myers Squibb (Expired Dec. 2009) CV Therapeutics (Expired Dec. 2007) Pfizer (Expired Dec. Takeda (Expired None Merck (Expired Dec. None None 4.4.1.1 Jonathan Abrams University of New Mexico, Office of CME Professor of Medicine (Cardiology) None None None None None None None Kathleen Berra Stanford Prevention Research Center Clinical Trial Director Boehringer Ingelheim CV Therapeutics Gilead Sciences Novartis Pfizer Sanofi-aventis None Kai Pharmaceuticals PCNA Board Member James C. Blankenship Geisinger Medical Center Director Cardiology; Director Cardiac Catheterization Laboratory None Sanofi-aventis None Abiomed AstraZeneca Boston Scientific Conor Medsystems Kai Pharmaceutical Novartis Schering-Plough The Medicines Company None None 4.4.2.1 Apostolos P. Dallas Carilion Roanoke Memorial Hospital Director of Continuing Medical Education None None GlaxoSmithKline Johnson & Johnson Novartis Sanofi-aventis None None None 4.4.1.1 Pamela S. Douglas Duke University Medical Center Ursula Geller Professor of Research in Cardiovascular Diseases None None None Novartis None None 4.4.1.1 JoAnne M. Foody Harvard Medical School Associate Professor; Brigham and Women s/Faulkner Hospitals Abbott Amarin Gilead Merck Novartis Pfizer Sanofi-aventis None None None None None 2.2.2.2 Thomas C. Gerber Mayo Clinic Radiology, Professor of Medicine None None None None None None None Alan L. Hinderliter University of North Carolina: Division of Cardiology Associate Professor None None None None None None None Spencer B. King III Saint Joseph s Heart and Vascular Institute President; Saint Joseph s Health System Executive Director Academic Affairs Medtronic (Expired None None None Merck (DSMB) Wyeth Pharmaceuticals (DSMB) (Continued) Fihn et al Stable Ischemic Heart Disease: Full Text e465 Appendix 1. 